Quinze-Vingts National Ophthalmology Hospital

The Quinze-Vingts National Ophthalmology Hospital conducts trials focusing on eye diseases, including inherited retinal dystrophies, macular edema secondary to retinal vein occlusion, and gene‑therapy approaches for rod‑cone dystrophy. These studies aim to test new therapies, improve visual outcomes, and assess safety.

• Inherited retinal dystrophies
• Macular edema secondary to retinal vein occlusion
• Rod-cone dystrophy gene therapy

Patients at the Paris site can participate in cutting‑edge ocular research designed to preserve vision.

Research at the hospital also addresses immune system diseases affecting the eye, such as moderate‑to‑severe thyroid eye disease and steroid‑dependent non‑infectious uveitis. Trials evaluate biologic agents and immunosuppressive regimens to reduce inflammation and improve ocular function.

• Moderate-to-Severe Thyroid Eye Disease
• Non‑infectious intermediate, posterior and pan‑uveitis

These investigations seek to expand therapeutic options for patients with autoimmune ocular conditions.